EDGAR Filing Documents for 0001571049-17-006728

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001571049-17-006728

Filing Date

2017-07-17

Accepted

2017-07-17 08:57:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 3 TO FORM S-1	t1702095-s1a.htm	S-1/A	666886
2	EXHIBIT 1.1	t1702095_ex1-1.htm	EX-1.1	237568
3	EXHIBIT 3.5	t1702095_ex3-5.htm	EX-3.5	114615
4	EXHIBIT 4.3	t1702095_ex4-3.htm	EX-4.3	115960
5	EXHIBIT 5.1	t1702095_ex5-1.htm	EX-5.1	14000
6	EXHIBIT 23.1	t1702095_ex23-1.htm	EX-23.1	2401
7	GRAPHIC	lg_cyclacel-withregmark.jpg	GRAPHIC	124046
8	GRAPHIC	t1702095_ex5-1logo.jpg	GRAPHIC	5393
	Complete submission text file	0001571049-17-006728.txt		1331115

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)